In a positive year for the region's banks, 2025 ECM fees in Apac, ex Japan, were up 45% from 2024, DCM fees saw 11% growth, amid a record year for bonds, while M&A advisory fees climbed 43%.

The second foreign currency-denominated sovereign bond from China within a month has seen record popularity, and was oversubscribed 25 times.

The Asia-based travel experience platform revealed adjusted EBITDA profits for the first time in its public filing to the SEC.

The HK$155 a share offer is a 33% premium over Hang Seng's 30-day average closing price; HSBC already owns 63% of the HKEX-listed bank. Hang Seng's after tax profits declined 30% in H1 2025. HSBC has paused buybacks.

Hong Kong-listed biotech firms are outperforming as Trump’s policies cause firms to change course from their traditional US destination, with more HKEX listings expected in the second half of 2025; experts shared their views at BIOHK.

The rationale behind all the winners in mainland China, Hong Kong, Mongolia, South Korea and Taiwan.